Loading...
Novel drugs that target the metabolic reprogramming in renal cell cancer
Molecular profiling studies of tumor tissue from patients with clear cell renal cell cancer (ccRCC) have revealed extensive metabolic reprogramming in this disease. Associations were found between metabolic reprogramming, histopathologic Fuhrman grade, and overall survival of patients. Large-scale g...
Na minha lista:
Udgivet i: | Cancer Metab |
---|---|
Main Authors: | , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4944519/ https://ncbi.nlm.nih.gov/pubmed/27418963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-016-0154-8 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|